The table below shows Bristol-Myers Squibb Company's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$48.19B
$48.30B
$45.01B
$46.16B
$46.38B
$42.52B
Cost of revenue
$13.94B
$13.97B
$10.69B
$10.14B
$9.94B
$11.77B
Gross profit
-
-
-
-
-
$30.75B
R&D
$9.95B
$11.16B
$9.30B
$9.51B
$10.20B
$10.05B
SG&A
BMY annual revenue (10-K history)
Bristol-Myers Squibb Company reported annual revenue of $48.19B for fiscal year 2025. That is down 0.2% from $48.30B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $19.43B (FY 2016) to $48.19B. Figures come from the company's audited annual reports as filed with the SEC.